Dr. Robert M. Cole, MD

Dr. Cole practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Cole's NPI, 1154646289, was assigned on March 31, 2010. Dr. Cole graduated from Boston University School Of Medicine in 2010. Dr. Cole's California license number on file is A118588.

Dr. Cole's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Cole's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. Dr. Cole is also affiliated with San Antonio Regional Hospital. The medical group on file is Cedars-Sinai Medical Group. Dmand AI also links Dr. Cole to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cole practices, 3 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Cole's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Cole is board certified in advanced heart failure and transplant cardiology by the American Board of Internal Medicine. Dr. Cole has a license on file in California.

Dmand AI lists aneurysm, aortic atherosclerois, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, chronic hypertension, coronary artery disease and heart attack among the conditions Dr. Cole treats.

CMS data shows 942 Medicare services from Dr. Cole across 13 procedure codes in 2024, for 255 Medicare patients. Medicare paid $82,481 for them.

CMS counts 255 Medicare patients who saw Dr. Cole in 2024. The largest group is 65 to 74, with 100 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 2.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cole's median patient age at 68, with 34% women.

In 2024, Dr. Cole wrote 1,102 Medicare Part D claims for 159 patients. 79% of them were for generic drugs. CMS names the drug for 885 of them, across 27 drugs with 11 or more claims each, at $1,097,478 in total drug cost. In 2023, CMS named 768 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Cole for performance year 2024, reported as part of a group. Dr. Cole accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cole as offering telehealth.

Dmand AI links 3 papers to Dr. Cole, published from 2019 to 2024. The most frequent topics are Heart-Assist Devices. Dr. Cole's most frequent co-authors are Dominic Emerson, MD, Dominick Joseph Megna, MD and Jaime D. Moriguchi, MD.

CMS Open Payments shows 48 general payments to Dr. Cole from 9 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 85% of the total. Abbott Laboratories paid the most, $1,349.

Dr. Cole graduated from Boston University School Of Medicine in 2010.

Dr. Cole is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.